Capsule Announces Reseller Agreement with InterSystems

InterSystemsCapsule Technologie, the leading global provider of medical device integration solutions, has signed a reseller agreement with InterSystems, a global leader in software for connected healthcare. Under the terms of the agreement, InterSystems will be authorized to resell Capsule's SmartLinx Medical Device Information System® (MDIS). The two companies' partnership stems from a shared vision of connected care and strong global market presence.

Capsule's SmartLinx MDIS is healthcare's first integrated system to enable hospitals and healthcare delivery organizations to increase efficiency and help improve patient care delivery through the capture of medical device data and context directly at the point of care. The system consolidates clinical workflow and puts data to work by integrating it with both electronic medical records and intelligent systems to drive informed clinical and operational decisions. Connectivity and data capture are achieved through integrated hardware and/or software solutions that meet the requirements of virtually any healthcare environment.

InterSystems TrakCare® is a unified healthcare information system that provides a comprehensive set of administrative and advanced clinical capabilities to rapidly enable a shared electronic medical record (EMR) across care settings. The partnership with Capsule will enable TrakCare customers to capture real-time observation data in ICU and operating theatres and store the data in the patient's EMR.

Both companies share a global presence while providing pre-configured solutions to meet the needs of local markets. "Establishing this partnership with Capsule is an exciting opportunity for both companies," said Christine Chapman, Vice President, TrakCare, at InterSystems. "The bundling of Capsule’s MDIS solution with TrakCare® will enable customers to seamlessly connect devices and make that data immediately available in the TrakCare EMR, triggering decision support, workflows and alerts for improved quality of care."

"Like InterSystems, Capsule works closely with our partners to localize our market strategy," said Didier Argenton, Capsule's Vice President of International Sales. "This agreement will facilitate entry into new markets and will contribute significantly in developing our presence worldwide."

Related news articles:

About Capsule
Capsule is the leading global provider of medical device integration solutions for hospitals and healthcare organizations. Capsule's SmartLinxMedical Device Information System® (MDIS) increases efficiency and helps improve patient care through the systematic real-time capture of patient vitals at the point-of-care and the delivery of those data to hospital electronic medical records, other information systems and third party mobile solutions. Capsule's solutions are flexible and scalable, offering a variety of deployment options to meet the needs of any healthcare delivery organization. Founded in 1997, the Company has established strong partnerships with leading medical device manufacturers and installed enterprise-wide solutions in over 1,800 hospitals in 38 countries.

About InterSystems
InterSystems develops advanced software technologies that enable breakthroughs. With a passion for excellence and a focus on client success, InterSystems provides data management, strategic interoperability, and analytics platforms used in healthcare, financial services, government, and other industries. In selected countries, InterSystems also offers unified healthcare applications, based on its core technologies, that deliver on the promise of connected healthcare. Founded in 1978, InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its products are used daily by millions of people in more than 100 countries.

Most Popular Now

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...